AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 277: G847-G854, 1999;
0193-1857/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reuter, B. K.
Right arrow Articles by Wallace, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reuter, B. K.
Right arrow Articles by Wallace, J. L.
Vol. 277, Issue 4, G847-G854, October 1999

Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNF-alpha release

Brian K. Reuter and John L. Wallace

Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1

Although the ability of nonsteriodal anti-inflammatory drugs (NSAIDs) to injure the small intestine has been well established in humans and animals, the mechanism involved in this type of injury has yet to be elucidated. The cytokine tumor necrosis factor-alpha (TNF-alpha ) has recently been demonstrated to play a critical role in the pathogenesis of NSAID-induced gastric damage. We therefore assessed the possibility that TNF-alpha is similarly involved in the pathogenesis of NSAID-induced small intestinal injury. Administration of multiple doses (n = 4) of diclofenac, but not a single dose, resulted in profound macroscopic damage in the intestine and significantly increased levels of TNF-alpha in intestinal tissue and bile. Pretreatment of rats with a phosphodiesterase inhibitor, pentoxifylline, theophylline, or rolipram, significantly attenuated the macroscopic intestinal ulceration produced by diclofenac administration. However, inhibition of TNF-alpha release with thalidomide or immunoneutralization with a polyclonal antibody directed against TNF-alpha failed to afford any protection. These results suggest that the cytokine TNF-alpha does not play a critical role in NSAID-induced small intestinal injury. Therefore, phosphodiesterase inhibitors mediate their protective effect through a mechanism independent of TNF-alpha synthesis inhibition.

ulcer; inflammation; enteritis; cyclooxygenase; nonsteroidal anti-inflammatory drugs; tumor necrosis factor-alpha


This article has been cited by other articles:


Home page
 GutHome page
S J H van Deventer
Small therapeutic molecules for the treatment of inflammatory bowel disease
Gut, May 1, 2002; 50(90003): iii47 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. A. Sneed, J. P. Buchweitz, P. A. Jean, and P. E. Ganey
Pentoxifylline Attenuates Bacterial Lipopolysaccharide-Induced Enhancement of Allyl Alcohol Hepatotoxicity
Toxicol. Sci., July 1, 2000; 56(1): 203 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Diaz-Granados, K. Howe, J. Lu, and D. M. McKay
Dextran Sulfate Sodium-Induced Colonic Histopathology, but not Altered Epithelial Ion Transport, Is Reduced by Inhibition of Phosphodiesterase Activity
Am. J. Pathol., June 1, 2000; 156(6): 2169 - 2177.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online